Note the clinical results based on Niebler et. al (2023) comparing different VADs in patients with a BSA of 0.7 to 1.4 m².   
 
The data was presented for the ACTION network at the ISHLT 2023. The associated paper can be found here:  https://lnkd.in/dReX83rx
 
Rob Niebler, ISHLT - International Society for Heart and Lung Transplantation 
 
#ourpatientsourmission #vad #pediatric 
 
++++++++++ 
 
The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only. 
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.